Ty Carroll, MD

Publications

• Hormonal Contraceptive Use Is Associated With a Decreased Incidence of Hypothyroidism.

  (Gloe S, Carroll TB.) Endocr Pract. 2024 Jan;30(1):36-40 PMID: 38178585 SCOPUS ID: 2-s2.0-85176932018 01/05/2024

• Constitutional mosaicism for a pathogenic variant in MEN1 associated with multiple endocrine neoplasia type I syndrome.

  (Jacquart A, Schilter KF, Udani R, Evans D, Carroll TB, Reddi HV.) Clin Genet. 2023 Jul;104(1):139-141 PMID: 36840469 SCOPUS ID: 2-s2.0-85149270134 02/26/2023

• Alcohol-induced Cushing syndrome: report of eight cases and review of the literature.

  (Surani A, Carroll TB, Javorsky BR, Raff H, Findling JW.) Front Endocrinol (Lausanne). 2023;14:1199091 PMID: 37409223 PMCID: PMC10319132 07/06/2023

• Response to the Letter to the Editor From Jialal and Sood: New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency After ACTH Stimulation Using Specific Cortisol Assays.

  (Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Jit Singh R, Colón-Franco JM, Findling JW.) J Endocr Soc. 2021 Sep 01;5(9):bvab113 PMID: 34278181 PMCID: PMC8279072 SCOPUS ID: 2-s2.0-85112025664 07/20/2021

• New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays.

  (Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Colón-Franco JM, Findling JW.) J Endocr Soc. 2021 Apr 01;5(4):bvab022 PMID: 33768189 PMCID: PMC7975762 03/27/2021

• Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome.

  (Kannankeril J, Carroll T, Findling JW, Javorsky B, Gunsolus IL, Phillips J, Raff H.) J Endocr Soc. 2020 Oct 01;4(10):bvaa107 PMID: 32935666 PMCID: PMC7480956 09/17/2020

• Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol.

  (Carroll TB, Peppard WJ, Herrmann DJ, Javorsky BR, Wang TS, Patel H, Zarnecki K, Findling JW.) J Endocr Soc. 2019 Jan 01;3(1):1-12 PMID: 30560224 PMCID: PMC6291660 12/19/2018

• Parathyroidectomy for primary hyperparathyroidism improves sleep quality: A prospective study.

  (La J, Wang TS, Hammad AY, Burgardt L, Doffek K, Carr AA, Shaker JL, Carroll TB, Evans DB, Yen TW.) Surgery. 2017 Jan;161(1):25-34 PMID: 27865592 SCOPUS ID: 2-s2.0-85006241153 11/21/2016

• POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.

  (Carroll TB, Javorsky BR, Findling JW.) Endocr Pract. 2016 Oct;22(10):1216-1223 PMID: 27409817 SCOPUS ID: 2-s2.0-85014159108 07/14/2016

• Response to comments on: Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy following adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.

  (Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS.) Surgery. 2016 Jul;160(1):249-250 PMID: 27181385 SCOPUS ID: 2-s2.0-84966473508 05/18/2016

• Delayed Calcium Normalization After Presumed Curative Parathyroidectomy is Not Associated with the Development of Persistent or Recurrent Primary Hyperparathyroidism.

  (Lai V, Yen TW, Doffek K, Carr AA, Carroll TB, Fareau GG, Evans DB, Wang TS.) Ann Surg Oncol. 2016 Jul;23(7):2310-4 PMID: 27006125 SCOPUS ID: 2-s2.0-84961848458 03/24/2016

• Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.

  (Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS.) Surgery. 2016 Jan;159(1):259-65 PMID: 26422766 SCOPUS ID: 2-s2.0-84952637438 10/01/2015